chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low grade fever (max 100.6 degF) developed ~12hours after injection and lasted ~12hours.; Body aches and chills accompained the fever but faded when it did; Body aches and chills accompained the fever but faded when it did; Injection site soreness lasted - 48 hours; This is a spontaneous report from a contactable consumer reported for herself. A 23-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), dose 2 via an unspecified route of administration, administered in Arm Left on 25Feb2021 11:00 (at the age of 23-years-old) as a single dose for covid-19 immunization. The patient medical history was not reported. Concomitant medication(s) received within 2 weeks of vaccination included acetaminophen; ibuprofen. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247), dose 1 via an unspecified route of administration, administered in Arm Left on 04Feb2021 11:00 (at the age of 23-years-old) as a single dose for covid-19 immunization. The patient had allergy with nitrofurantoin. The patient was not pregnant at the time of vaccination. The patient had no other vaccine within four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26Feb2021 02:00, the patient experienced low grade fever (max 100.6 degF) developed approximately 12hours after injection and lasted approximately 12hours. Body aches and chills accompanied the fever but faded when it did. Injection site soreness lasted approximately 48hours. The patient did not receive any treatment. Outcome of the event was not recovered, at the time of this report.  Follow-up attempts completed. No follow-up attempts are needed. No further information is expected.
Fever 103, high pitched screaming 6+ hours, 72 hrs total fever and fussy.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 84-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported. Reporter states that Time from first puncture was 4 days   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received  on 29-sep-2021 and contains non significant information
Patient went to bed at night on 8/18/23.  She felt pain in her stomach lik glass cutting her stomach. It stopped 8/19/23 in AM.  Then in AM of 8/19/23 she felt arthritic pain in legs, thighs + back Went away by 8/21/23
Presented to ED after 24 hours of minimal po intake and poor responsiveness. Initially asystolic, hypoglycemic (27) with profound metabolic acidosis. Intubated 20 hours after PICU admission when generalized seizures began. Mechanical ventilation x 5 days. Extensive metabolic work up, high glucose/insulin infusion. Discharged on Topiramate & Phenobarb with evidence of hypoxic encephalopathy & suspect cortical blindness.
This case was reported by a pharmacist and described the occurrence of fever in a 22-year-old male subject who was vaccinated with BOOSTRIX (GlaxoSmithKline). On 11 July 2012 the subject received a dose of BOOSTRIX (.5 ml, unknown route). On 11 or 12 July 2012, less than one day after vaccination with BOOSTRIX, the subject experienced fever and chills. In July 2012, the events were resolved within 3 days. The pharmacist reported two subjects were vaccinated on the same day with same lots of BOOSTRIX at the same pharmacy complained of fever and chills with onset within 1 day of vaccination and resolution within 3 days. See case A098745A for details regarding the other subject. On 08 August 2012, updated lot number information was received from a safety review. The lot number was reported as A152B078AA from the reporter; however, based on safety lot number review, the lot was updated to AC52B078AA.
3/23 - felt dizzy on morning walk. Unstable and made a mental of 'walking funny'. Progressed over next several hours to headache, chest and stomach/ back pain. General malaise, muscle aches and Nausea. At 1pm went to ER - concerned about heart attack. Sweating and palpitations. ECG and Cat Scan performed, Lots of bloodwork. Vomited at hospital. Discharged at 4:30pm - diagnosed as hypertension - 141mmhg/89 /GERD. can provide all labwork. of note: HgB-high, MCHC -high, Mono Auto - high, Glucose- high, given anti-nausea med, antacid, high blood pressure med. 3/24 - still vomiting. Called local doctor - no high blood pressure- told to stop taking this medication. Continue with anti nausea Zofran ODT.
Patient came into the pharmacy with his father to get the meningitis vaccine as requested by his high school and the HPV vaccine as requested by his mother who is a nurse.  Menactra was administered in his left arm and he switched chairs to give the RPh easier access to give the other vaccination. The Gardasil 9 was given in the right arm.  When patient stood up after the vaccinations he said he felt dizzy so he sat back down.  A pharmacy technician was called to help lay the patient on the floor .  The RPH talked with the patient as the technician held his feet up off the ground.  His pulse and blood pressures were taken results as follows, 5:27 101/51 & 43,  5:28 108/47 & 44, & 5:31 97/52 & 52. after about 10 minutes the patient said he felt better and sat upright in the chair.  His father went to get him a snack and a drink.  When the father returned the patient felt better still they walked around/stayed in the store before going home.  An hour later the patient's mother came to the pharmacy to get an administration record to give to the school as proof of getting the Menactra and to tell us that the patient was feeling fine.  She also wanted to get the return dates for the remaining Gardisil 9 shots.
New-onset guttate psoriasis. The first skin lesion was noticed on right forearm sometime after first dose of vaccine, then started spreading to torso and other extremities after second dose of vaccine on 2/26/21 (Moderna lot# 013A21A).
09/19/2006 MMR and HBV adm 1, 10/03/2006 swollen glands, numbness and tingling of arm and legs bilat. Pt called hotline and states she was told this was from the MMR. 10/15/06 chest pain. Pt wonders if this is related to immunizations.
diarrhea; vaccination site rash; myalgia; Fatigue; tiredness; Vaccination site pruritus; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE RASH (vaccination site rash), MYALGIA (myalgia), FATIGUE (Fatigue), FATIGUE (tiredness) and VACCINATION SITE PRURITUS (Vaccination site pruritus) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Apr-2021, the patient experienced VACCINATION SITE RASH (vaccination site rash), MYALGIA (myalgia), FATIGUE (Fatigue), FATIGUE (tiredness) and VACCINATION SITE PRURITUS (Vaccination site pruritus). On 30-Apr-2021, the patient experienced DIARRHOEA (diarrhea). At the time of the report, VACCINATION SITE RASH (vaccination site rash), MYALGIA (myalgia), FATIGUE (Fatigue), FATIGUE (tiredness), VACCINATION SITE PRURITUS (Vaccination site pruritus) and DIARRHOEA (diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant products and treatment medication were reported.
Tested positive for Covid; Tested positive for Covid; This is a spontaneous report received from a non-contactable reporter (Consumer or other non HCP). The reporter is the patient.  A 41-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 20Jan2023 as dose 4 (booster), single (Lot number: GL0446) at the age of 40 years, in left arm for COVID-19 immunisation; BNT162b2 (BNT162B2), on 01Mar2021 as dose 1, single (Lot number: EN6205), in left arm, on 29Mar2021 as dose 2, single (Lot number: ER8730), in left arm and on 19Nov2021 as dose 3 (booster), single (Lot number: EW0217), in left arm for COVID-19 immunisation. The patient's relevant medical history included: "Arthritis" (unspecified if ongoing); "rosacea" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 16Aug2023, outcome "not recovered" and all described as "Tested positive for Covid". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (16Aug2023) Positive; (24Aug2023) Negative; (27Aug2023) Positive; (29Aug2023) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19. Additional information: The patient has no known allergies. The patient was tested positive for COVID on 16Aug2023, was given Paxlovid on 17Aug2023, finished course on 21Aug2023, tested negative on 24Aug2023 with no symptoms, 26Aug2023 started with symptoms again, tested positive on 27Aug2023 with continued symptoms still positive with symptoms as of today 29Aug2023.  No follow-up attempts are possible. No further information is expected.
7-12-07 - employee c/o itching immediately after injection. After 20 min. no worsening - actually improved. Employee went home. 7-19-07 / 4:00 Employee calls to say that on 7-12-07 2-3 hours after inj. c/o itching and hives - took her Allegra, went home from work - had stomach upset and diarrhea - resolved by morning 7-13-07.
On the 11th day after receiving the covid booster I broke out in hives, all over my body from head to toe coming and going in different places and extremely itchy after a few days of Benadryl the hives still continued to come and I met with a dermatologist who confirmed he has seen some similar adverse reactions with some other patients and typically can last 3-6 weeks before usually resolving. He prescribed fexofenadine 180 mg twice daily along with 10 mg hydroxyzine every 6 hours as needed for breakthrough hives, and requested I make a follow up appointment for 3 weeks.
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Vaccine was to be administered on or before 5/5/21 at 1500 and was given on 5/6/21 at 1000.  Reported to Pfizer as well.
This spontaneous case reported by a consumer, describes the occurrence of vaccination site bruising (bruising at site of injection), vaccination site pruritus (severe itching at site of injection), vaccination site induration (hardness at the injection site), vaccination site swelling (swelling the size of a golf ball at the injection site) and vaccination site pain (tenderness at site of injection) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 026B21A) for COVID-19 immunization. No reported medical history. On Apr 1, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 1, 2021, patient experienced vaccination site bruising (bruising at site of injection), vaccination site pruritus (severe itching at site of injection), vaccination site induration (hardness at the injection site), vaccination site swelling (swelling the size of a golf ball at the injection site) and vaccination site pain (tenderness at site of injection). The patient treated with ibuprofen, at an unspecified dose and frequency. At the time of the report, vaccination site bruising (bruising at site of injection), vaccination site pruritus (severe itching at site of injection), vaccination site induration (hardness at the injection site), vaccination site swelling (swelling the size of a golf ball at the injection site) and vaccination site pain (tenderness at site of injection) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. Concomitant product use not provided.
Information has been received from a nurse concerning a "13-15" year old female patient who on an unknown date was vaccinated with a dose of GARDASIL (Lot No. not reported). The patient fainted after receiving GARDASIL. The patient sought unspecified medical attention. At the time of the report, the patient had recovered. This is one of two reports received from the same source. Additional information has been requested.
Patient c/o anterior cp onset 1200 noon 27 June 2013 while sitting in a briefing. Pain increased with movement and deep breathing. Non radiating, no SOB, nausea or vomiting. Patient presented to the emergency department at 1750 by private auto. BP 137/92 HR 67, Resp 18, SA02 99%. Temp 98.5. Patient was given Naproxen, Diagnostic tests: CXR, Trop, CBC, Chem, EKG.
fever; This is a spontaneous report from a contactable other health care professional. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, Reporter stated that a nurse (Patient) at the vaccination site had a fever after the second shot of Pfizer vaccine. The outcome of the event was unknown.  Follow-up attempts are completed. No further information is expected.
Patient received 0.5ml of FLUZONE vaccine instead of 0.25ml on 10/22/18.
After vaccine I woke up about 1am extremely cold, chills and shaking, I tried to go to the bathroom and really started shaking and couldn't sleep, had a headache and couldn't sleep. I had no appetite when I woke up at 6am, took my morning meds and went back to bed. Noon I felt a little better and it gradually went away and it seem to gradually go away. Because I have an auto-immune disease I seem to have had a reaction to the vaccine because it did not bother my wife, except for her being a little tired.
Information has been received from a health professional concerning an approximately 24 month old female who in October 2007, was vaccinated with varicella virus vaccine live (Oka/Merck). In November 2007, the patient developed a zoster like rash. At the time of this report, the patient has not recovered. A product quality complaint was not reported. Additional information has been requested.
Have neuropathy symptoms; pain; patient has had tingling; This serious case was reported by a physician via sales rep and described the occurrence of neuropathy in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (left arm). In DEC-2022, an unknown time after receiving Shingrix, the patient experienced tingling sensation (Verbatim: patient has had tingling). On an unknown date, the patient experienced neuropathy (Verbatim: Have neuropathy symptoms) (serious criteria GSK medically significant) and pain (Verbatim: pain). The outcome of the neuropathy was not resolved and the outcome of the tingling sensation was not reported and the outcome of the pain was resolved.   It was unknown if the reporter considered the neuropathy, tingling sensation and pain to be related to Shingrix.     It was unknown if the company considered the neuropathy, tingling sensation and pain to be related to Shingrix.   Additional Information: GSK Receipt date- 11-APR-2023 The reporter reported that patient has had tingling sensation since 1st dose, pain had resolved but continues to had neuropathy symptoms. The reporter agreed to follow up from GSK.
she is not sure if she got the full dose or not; She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose; This spontaneous case was reported by a consumer and describes the occurrence of UNDERDOSE (she is not sure if she got the full dose or not) and DEVICE CONNECTION ISSUE (She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001L21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced UNDERDOSE (she is not sure if she got the full dose or not) and DEVICE CONNECTION ISSUE (She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose). On 22-Apr-2021, UNDERDOSE (she is not sure if she got the full dose or not) and DEVICE CONNECTION ISSUE (She reports that some liquid dripped down the arm while vaccine provider was giving 2nd dose) had resolved. Not Provided          Action taken with mRNA-1273 in response to the events was not applicable. No concomitant medications information was reported. No treatment medications were provided.
on 2/218/2021 the patient was at home and developed chest pain. Patient was transported by family to urgent care then to the ED where the patient later died.
At the time of the injection, I immediately felt a lot of pain on the arm that extended to the elbow and up to the neck (under the jaw). I figured that was normal and simply waited about 25 minutes there. I got home and at about 3 pm, I began to feel tingling on the left leg, mostly on the front (toes and padded area) of the foot. I began to get nervous due to my past GB experience. About an hour later, I began to feel the same on the right foot, same area. Right now it is 5:07 pm and I feel the same.
Patient presented in office 0130 after receiving vaccines at approximately 1200 noon complaining of hives all over and difficulty swallowing - 6cc BENADRYL, 1 tsp ORAPRED and 0.15ml epinephrine SQ (R) arm given - of relevance pt has beef/pork allergy secondary to alpha-gal.
Diarrhoea; severe fatigue/felt very drained; ran a fever; headache; sore arm/pain in my right leg; my right leg went numb; my arm was bruised; This is a spontaneous report from a contactable consumer (patient) via medical information team. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) Solution for injection, via an unspecified route of administration on 22Apr2021 (Batch/Lot number was not reported) as single dose for COVID-19 immunization. Medical history included, patient had flu (influenza from Jan2020 to Jan2020) which took her down for 5 days and it was all covid symptoms but never got tested. There were no concomitant medications reported. On 22Apr2021 few hours after the vaccination, the patient had sore arm and the arm was bruised but then the patient thought it to be ok. The patient reported that on 24Apr2021 (past Saturday as reported) while driving the patient felt pain in right leg that went down to the foot and it went numb, she thought it could be a blood clot or having a stroke, but it was not. The next day on 25Apr2021 the patient experienced diarrhoea, severe fatigue, ran a fever, headache. She could not get out of bed, she felt very drained. She also mentioned that she is doing better now but this was pretty severe. The outcome of the events was reported as recovering.  No follow-up attempts are needed. No information about lot/batch number cannot be obtained.
Totally lethargic within 10 minutes, itching and throat started to close up, could hardly swallow.
Itchiness at the injection site; She started experiencing Hives at injection site; Redness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE URTICARIA (She started experiencing Hives at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE URTICARIA (She started experiencing Hives at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site). At the time of the report, VACCINATION SITE PRURITUS (Itchiness at the injection site), VACCINATION SITE URTICARIA (She started experiencing Hives at injection site) and VACCINATION SITE ERYTHEMA (Redness at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pfizer-BioNtech COVID-19 Vaccine EUA  Fever, joint pain, swollen nymph nodes, arm pain.
No adverse event. OFF LABEL USE. Patient did receive 2nd dose Moderna today with LOT#037A21B with no adverse reaction/event. Per MD note, vaccine to be administered.
Initial unsolicited report received from a physician on 07 Oct 2016. This case involves a female patient (age not reported) who as vaccinated with a dose of INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (High dose flu) and PNEUMOCOCCAL VACCINE (manufacturer: unknown) (batch number, expiry date, route of administration: not reported for both vaccines) both in same arm at same time on unspecified date. Patient's medical history and concomitant medications were not reported. On an unspecified date, after vaccination, the patient went in for blood work and arm was red from injection area. Patient's laboratory data and corrective treatment was not reported. The outcome of the event was not reported. List of documents held by sender: none.